Tumor-induced extramedullary hematopoiesis produces abundant CD71 (transferrin receptor 1) positive EPCs suggesting that neutralizing CD71 could be an effective strategy to deplete these robust immunosuppressors. This evidence concerns the gene TFRC and neoplasm.